Measles IgG
Measles virus IgG assay is employed for the qualitative determination of IgG class antibodies against Measles virus in serum. This assay is performed in case of Measles symptoms or difficulties due to Measles ailment. It aids healthcare providers to assess if the individual was previously exposed to measles virus or was vaccinated and provide effective intervention. […]
Hepatitis E IgG/IgM Ab
The Hepatitis E IgG/IgM Antibody test detects IgG and IgM antibodies against the hepatitis E virus (HEV). IgM antibodies emerge first, followed by IgG. IgM is detectable for 3–4 months, while IgG lasts longer. Known for its high specificity and sensitivity, this test is used by healthcare professionals to identify acute HEV infections and screen […]
Hepatitis C Virus (HCV) Antibody Screen
The Hepatitis C Antibody detects antibodies against the hepatitis C virus (HCV), often contracted through blood contact or needle sharing, leading to conditions like cirrhosis and liver cancer. Pregnant women, immunocompromised persons, and transplant patients are advised to take this test. Healthcare providers use it to detect HCV exposure, post-transfusion hepatitis, recent infections, or carrier […]
Hepatitis B e Antigen
The Hepatitis B e Antigen test detects the presence of the hepatitis B virus’s (HBV) E antigen, usually appearing 4 to 12 weeks after infection and lasting 3 to 6 weeks. HBeAg levels correspond to virus levels, aiding in assessing infectivity. Its presence indicates an infectious disease stage. Healthcare providers use this to gauge infectivity […]
Hepatitis B e Antibody
The Hepatitis B e Antibody test detects anti-HBe antibodies against antigens of hepatitis B virus detectable 8 to 16 weeks post-infection. Determining the presence or absence of detectable hepatitis B e antibody in monitoring infection status of individuals with chronic hepatitis B. Determining infectivity of hepatitis B virus (HBV) carriers Anti-HBe usually remains detectable for […]
Hepatitis B Surface Antigen Screen
A hepatitis B surface antigen (HBsAg) assay can be combined with other serological and clinical information to diagnose people suffering from acute or chronic hepatitis B infection. This assay may also be employed to screen for hepatitis B infection in the case of pregnant women to recognise neonates who are at risk of acquiring hepatitis […]
Hepatitis B Surface Antibody
The Hepatitis B surface antibody test determines the antibodies produced in response to Hepatitis B exposure or vaccination. A positive result indicates immunity from past infection or vaccination. Conversely, a negative outcome suggests susceptibility to Hepatitis B. This test crucially determines immune status against the virus.
Hepatitis B screen (HBsAg + HBcAb)
The Hepatitis B screening test detects Hepatitis B surface antigen (HBsAg) and Hepatitis B core antibody (HBcAb). HBsAg indicates active HBV infection, HBcAb suggests past or ongoing infection. This comprehensive test aids in diagnosing Hepatitis B, distinguishing between acute and chronic phases, and assessing immunity post-infection and identifying individuals at risk of transmitting the virus.
Hepatitis B Markers
The Hepatitis B Markers test detects hepatitis B virus (HBV), by using serological markers. This test aids as an initial diagnostic step for detecting antigens and antibodies associated with HBV, assessing the clinical phases of infection, and monitoring the effectiveness of antiviral therapy. This Hepatitis B Markers group includes Hepatitis B surface Antigen (HBsAg) Confirmation, […]
Hepatitis B Core Antibody IgM
The Hepatitis B Core IgM Antibody confirmation test is performed to identify the presence of the IgM antibody to the hepatitis B virus (HBV). HBV is typically acquired through various means such as mother-to-child transmission, blood contact, or sexual contact. The presence of IgM anti-HBc indicates acute or recent infections within the last 6 months.
